{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:03:29Z","timestamp":1776924209811,"version":"3.51.2"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009743","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000}}],"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI137127"],"award-info":[{"award-number":["R01AI137127"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI057266"],"award-info":[{"award-number":["U19AI057266"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p><jats:italic>Vibrio cholerae<\/jats:italic>is a bacterial pathogen which causes the severe acute diarrheal disease cholera. Given that a symptomatic incident of cholera can lead to long term protection, a thorough understanding of the immune response to this pathogen is needed to identify parameters critical to the generation and durability of immunity. To approach this, we utilized a live attenuated cholera vaccine to model the response to<jats:italic>V<\/jats:italic>.<jats:italic>cholerae<\/jats:italic>infection in 12 na\u00efve subjects. We found that this live attenuated vaccine induced durable vibriocidal antibody titers that were maintained at least one year after vaccination. Similar to what we previously reported in infected patients from Bangladesh, we found that vaccination induced plasmablast responses were primarily specific to the two immunodominant antigens lipopolysaccharide (LPS) and cholera toxin (CT). Interestingly, the magnitude of the early plasmablast response at day 7 predicted the serological outcome of vaccination at day 30. However, this correlation was no longer present at later timepoints. The acute responses displayed preferential immunoglobulin isotype usage, with LPS specific cells being largely IgM or IgA producing, while cholera toxin responses were predominantly IgG. Finally, CCR9 was highly expressed on vaccine induced plasmablasts, especially on IgM and IgA producing cells, suggesting a role in migration to the gastrointestinal tract. Collectively, these findings demonstrate that the use of a live attenuated cholera vaccine is an effective tool to examine the primary and long-term immune response following<jats:italic>V<\/jats:italic>.<jats:italic>cholerae<\/jats:italic>exposure. Additionally, it provides insight into the phenotype and specificity of the cells which likely return to and mediate immunity at the intestinal mucosa. A thorough understanding of these properties both in peripheral blood and in the intestinal mucosae will inform future vaccine development against both cholera and other mucosal pathogens.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03251495\" xlink:type=\"simple\">NCT03251495<\/jats:ext-link>.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009743","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T17:42:14Z","timestamp":1630690934000},"page":"e0009743","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4306-7294","authenticated-orcid":true,"given":"Oluwaseyi","family":"Adekunle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Dretler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-5903","authenticated-orcid":true,"given":"Robert C.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-6148","authenticated-orcid":true,"given":"Alice","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7349-9197","authenticated-orcid":true,"given":"Jens","family":"Wrammert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"6","key":"pntd.0009743.ref001","article-title":"Updated Global Burden of Cholera in Endemic Countries","volume":"9","author":"M Ali","year":"2015","journal-title":"Plos Neglect Trop D"},{"key":"pntd.0009743.ref002","article-title":"Cholera in Yemen\u2014An Old Foe Rearing Its Ugly Head","author":"F Qadri","year":"2017","journal-title":"N Engl J Med"},{"issue":"37","key":"pntd.0009743.ref003","first-page":"441","article-title":"Weekly Epidemiological Record. Weekly Epidemiological Record = Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire","volume":"95","author":"WHOOmdl Sant\u00e9","year":"2020"},{"issue":"5","key":"pntd.0009743.ref004","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"WH Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"2","key":"pntd.0009743.ref005","first-page":"187","article-title":"Report of the 1966\u201367 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population\u2014the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae","volume":"40","author":"WH Mosley","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"2","key":"pntd.0009743.ref006","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/151.2.236","article-title":"Seroepidemiological Studies of El-Tor Cholera in Bangladesh\u2014Association of Serum Antibody-Levels with Protection","volume":"151","author":"RI Glass","year":"1985","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"pntd.0009743.ref007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/CVI.00378-14","article-title":"Critical analysis of compositions and protective efficacies of oral killed cholera vaccines","volume":"21","author":"S Kabir","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"pntd.0009743.ref008","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00626-16","article-title":"Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility","volume":"85","author":"Z Wang","year":"2017","journal-title":"Infect Immun"},{"issue":"3","key":"pntd.0009743.ref009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"MM Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"pntd.0009743.ref010","article-title":"Global Economic Evaluation of Oral Cholera Vaccine","author":"SL Teoh","year":"2017","journal-title":"A Systematic Review. Hum Vaccin Immunother"},{"issue":"10101","key":"pntd.0009743.ref011","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera.","volume":"390","author":"JD Clemens","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"pntd.0009743.ref012","article-title":"Cholera","volume":"4","author":"D Lippi","year":"2016"},{"issue":"2","key":"pntd.0009743.ref013","first-page":"277","article-title":"Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique","volume":"38","author":"AS Benenson","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"1","key":"pntd.0009743.ref014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0035-9203(79)90119-6","article-title":"Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity","volume":"73","author":"MM Levine","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"pntd.0009743.ref015","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"D Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"pntd.0009743.ref016","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.smim.2018.02.008","article-title":"The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function","volume":"37","author":"C Sina","year":"2018","journal-title":"Semin Immunol"},{"key":"pntd.0009743.ref017","first-page":"17","article-title":"Do antimicrobial peptides and complement collaborate in the intestinal mucosa?","volume":"6","author":"ZA Kopp","year":"2015","journal-title":"Front Immunol"},{"issue":"9","key":"pntd.0009743.ref018","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1097\/MIB.0000000000000056","article-title":"The complement system in inflammatory bowel disease","volume":"20","author":"U Jain","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"pntd.0009743.ref019","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/mi.2016.59","article-title":"The human intestinal B-cell response","volume":"9","author":"J Spencer","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"3","key":"pntd.0009743.ref020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/CVI.00481-10","article-title":"Mucosal immunologic responses in cholera patients in Bangladesh.","volume":"18","author":"T Uddin","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"pntd.0009743.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02021-16","article-title":"Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells","volume":"7","author":"RC Kauffman","year":"2016","journal-title":"MBio"},{"issue":"12","key":"pntd.0009743.ref022","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1128\/JVI.03203-15","article-title":"B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.","volume":"90","author":"L Priyamvada","year":"2016","journal-title":"J Virol"},{"issue":"28","key":"pntd.0009743.ref023","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"L Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pntd.0009743.ref024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tmaid.2016.07.003","article-title":"Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR.","volume":"14","author":"C Herzog","year":"2016","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"pntd.0009743.ref025","first-page":"345","article-title":"A Recombinant Live Oral Cholera Vaccine","volume":"2","author":"JB Kaper","year":"1984","journal-title":"Bio\/Technology"},{"issue":"8609","key":"pntd.0009743.ref026","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.","volume":"2","author":"MM Levine","year":"1988","journal-title":"Lancet"},{"issue":"11","key":"pntd.0009743.ref027","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor","volume":"62","author":"WH Chen","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0009743.ref028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"WH Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"pntd.0009743.ref029","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","article-title":"Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand","volume":"165","author":"P Su-Arehawaratana","year":"1992","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"pntd.0009743.ref030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"S Crotty","year":"2004","journal-title":"J Immunol Methods"},{"issue":"5","key":"pntd.0009743.ref031","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CVI.00647-15","article-title":"O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh","volume":"23","author":"A Aktar","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pntd.0009743.ref032","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/jcm.26.2.328-332.1988","article-title":"Sensitivity and specificity of viral immunoglobulin M determination by indirect enzyme-linked immunosorbent assay","volume":"26","author":"H Champsaur","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"2","key":"pntd.0009743.ref033","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/jcm.9.2.170-174.1979","article-title":"Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence","volume":"9","author":"N Pyndiah","year":"1979","journal-title":"J Clin Microbiol"},{"issue":"10","key":"pntd.0009743.ref034","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/CVI.00347-13","article-title":"Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh","volume":"20","author":"A Rahman","year":"2013","journal-title":"Clin Vaccine Immunol."},{"issue":"6","key":"pntd.0009743.ref035","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/CVI.00037-12","article-title":"Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh","volume":"19","author":"SM Patel","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"pntd.0009743.ref036","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CVI.05615-11","article-title":"Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.","volume":"19","author":"DT Leung","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"24","key":"pntd.0009743.ref037","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood.2019002782","article-title":"Comprehensive analyses of B-cell compartments across the human body reveal novel subsets and a gut-resident memory phenotype","volume":"136","author":"NM Weisel","year":"2020","journal-title":"Blood"},{"issue":"12","key":"pntd.0009743.ref038","article-title":"Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab","volume":"2","author":"A Cho","year":"2017","journal-title":"JCI Insight."},{"issue":"7","key":"pntd.0009743.ref039","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1060028017698162","article-title":"Vaxchora: A Single-Dose Oral Cholera Vaccine","volume":"51","author":"A Cabrera","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"8821","key":"pntd.0009743.ref040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children","volume":"340","author":"Suharyono","year":"1992","journal-title":"The Lancet"},{"issue":"4","key":"pntd.0009743.ref041","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"CO Tacket","year":"1992","journal-title":"J Infect Dis"},{"issue":"6","key":"pntd.0009743.ref042","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","article-title":"Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera","volume":"163","author":"JD Clemens","year":"1991","journal-title":"J Infect Dis"},{"issue":"9","key":"pntd.0009743.ref043","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/IAI.00369-09","article-title":"Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.","volume":"77","author":"AM Harris","year":"2009","journal-title":"Infect Immun"},{"issue":"11","key":"pntd.0009743.ref044","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0264-410X(94)90335-2","article-title":"Kinetics of the vibriocidal antibody response to live oral cholera vaccines","volume":"12","author":"SS Wasserman","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"pntd.0009743.ref045","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/CVI.00562-10","article-title":"Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera","volume":"18","author":"MM Alam","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"pntd.0009743.ref046","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","article-title":"Duration of infection-derived immunity to cholera","volume":"143","author":"MM Levine","year":"1981","journal-title":"J Infect Dis"},{"key":"pntd.0009743.ref047","article-title":"Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12\u201317 Years in the United States","author":"JM McCarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0009743.ref048","doi-asserted-by":"crossref","first-page":"e0213507","DOI":"10.1371\/journal.pone.0213507","article-title":"IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity","volume":"14","author":"JS Yang","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0009743.ref049","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/infdis\/116.5.630","article-title":"Vibriocidal and agglutinating antibody patterns in cholera patients","volume":"116","author":"RB Sack","year":"1966","journal-title":"J Infect Dis"},{"issue":"11","key":"pntd.0009743.ref050","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/CVI.00321-12","article-title":"Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera","volume":"19","author":"RA Johnson","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"pntd.0009743.ref051","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4269\/ajtmh.13-0498","article-title":"Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera","volume":"90","author":"T Uddin","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0009743.ref052","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.168.4.1487","article-title":"Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans","volume":"168","author":"DA Herrington","year":"1988","journal-title":"J Exp Med"},{"issue":"6","key":"pntd.0009743.ref053","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.132.6.2736","article-title":"Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin","volume":"132","author":"CO Elson","year":"1984","journal-title":"J Immunol"},{"issue":"1","key":"pntd.0009743.ref054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/infdis\/129.1.45","article-title":"Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum","volume":"129","author":"RA Cash","year":"1974","journal-title":"J Infect Dis"},{"issue":"12","key":"pntd.0009743.ref055","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination","volume":"67","author":"CO Tacket","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"pntd.0009743.ref056","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/iai.60.10.4430-4432.1992","article-title":"Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial","volume":"60","author":"KL Kotloff","year":"1992","journal-title":"Infect Immun"},{"key":"pntd.0009743.ref057","article-title":"Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naive Population.","author":"DJ Haney","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"pntd.0009743.ref058","article-title":"The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae","volume":"24","author":"LM Mayo-Smith","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pntd.0009743.ref059","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/iai.61.2.729-733.1993","article-title":"Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection","volume":"61","author":"GA Losonsky","year":"1993","journal-title":"Infect Immun"},{"issue":"5790","key":"pntd.0009743.ref060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/288499a0","article-title":"Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin","volume":"288","author":"WS Dallas","year":"1980","journal-title":"Nature"},{"issue":"6","key":"pntd.0009743.ref061","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2958.1995.tb02289.x","article-title":"Identification of errors among database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae","volume":"15","author":"M Domenighini","year":"1995","journal-title":"Mol Microbiol"},{"issue":"8","key":"pntd.0009743.ref062","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3201\/eid2108.141364","article-title":"Escherichia coli O157 Outbreaks in the United States, 2003\u20132012","volume":"21","author":"KE Heiman","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pntd.0009743.ref063","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States\u2014major pathogens","volume":"17","author":"E Scallan","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009743.ref064","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2776(08)00405-7","article-title":"Human B cell subsets","volume":"98","author":"SM Jackson","year":"2008","journal-title":"Adv Immunol"},{"issue":"2","key":"pntd.0009743.ref065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte Trafficking to the Small Intestine and Colon","volume":"150","author":"A Habtezion","year":"2016","journal-title":"Gastroenterology"},{"issue":"5802","key":"pntd.0009743.ref066","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1132742","article-title":"Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells","volume":"314","author":"JR Mora","year":"2006","journal-title":"Science"},{"issue":"11","key":"pntd.0009743.ref067","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20080039","article-title":"Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo","volume":"205","author":"SI Hammerschmidt","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"pntd.0009743.ref068","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/mi.2015.77","article-title":"The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct","volume":"9","author":"SA Houston","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"4","key":"pntd.0009743.ref069","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4049\/jimmunol.1402708","article-title":"Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs","volume":"195","author":"MA Berkowska","year":"2015","journal-title":"J Immunol"},{"key":"pntd.0009743.ref070","doi-asserted-by":"crossref","first-page":"37295","DOI":"10.1038\/srep37295","article-title":"Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule","volume":"6","author":"L Kim","year":"2016","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009743","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T15:27:57Z","timestamp":1673191677000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009743"}},"subtitle":[],"editor":[{"given":"Franklin R.","family":"Toapanta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":70,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009743","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009743","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]}}}